Aarey Drugs & Pharmaceuticals Limited — Others, 02-01-2025: Shareholders meeting

Aarey Drugs and Pharmaceuticals has announced a board meeting to discuss key outcomes from its Fifth Extraordinary General Meeting. The company will issue 50,00,000 Convertible Warrants on a preferential basis and has re-appointed Mr. Lalit Tulsiani and Mr. Anil Mandal as Independent Directors. This move reflects Aarey's strategy to enhance its capital structure and strengthen governance. Investors may view these developments positively, as they signify growth potential and improved management oversight, although the issuance of warrants may dilute existing shares.